We found that ERO1α plays a critical role in integrin glycosylation and membrane transport in hypoxic tumour cells, and that ERO1α deletion leads to attenuated integrin signalling, including in tumour growth and epithelial-mesenchymal transition (EMT). Here, ERO1A is linked to neoplasm.